

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 9.04177783 |
| 2 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 9.04177783 |
| 3 | activated T cell proliferation (GO:0050798) | 8.93662461 |
| 4 | positive regulation of response to tumor cell (GO:0002836) | 8.63959748 |
| 5 | positive regulation of immune response to tumor cell (GO:0002839) | 8.63959748 |
| 6 | regulation of immune response to tumor cell (GO:0002837) | 8.63959748 |
| 7 | regulation of response to tumor cell (GO:0002834) | 8.63959748 |
| 8 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 8.12801744 |
| 9 | regulation of natural killer cell mediated immunity (GO:0002715) | 8.12801744 |
| 10 | negative T cell selection (GO:0043383) | 7.96471132 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.68087155 |
| 12 | negative thymic T cell selection (GO:0045060) | 7.32946799 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.02978375 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.02707003 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.02707003 |
| 16 | positive thymic T cell selection (GO:0045059) | 6.91585997 |
| 17 | positive T cell selection (GO:0043368) | 6.75918311 |
| 18 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 6.47030337 |
| 19 | thymic T cell selection (GO:0045061) | 6.30036379 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.94422912 |
| 21 | positive regulation of cell killing (GO:0031343) | 5.89652419 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.76160842 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.72979188 |
| 24 | T cell selection (GO:0045058) | 5.68893093 |
| 25 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.63398367 |
| 26 | positive regulation of B cell mediated immunity (GO:0002714) | 5.42548583 |
| 27 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.42548583 |
| 28 | response to interleukin-15 (GO:0070672) | 5.36109338 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.31328750 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 5.29284857 |
| 31 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.24642394 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 5.22144819 |
| 33 | T cell migration (GO:0072678) | 5.19931651 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.18260209 |
| 35 | regulation of cell killing (GO:0031341) | 5.12361042 |
| 36 | positive regulation of isotype switching (GO:0045830) | 5.04159302 |
| 37 | T cell costimulation (GO:0031295) | 5.01711643 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 4.93847335 |
| 39 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.93717014 |
| 40 | lymphocyte costimulation (GO:0031294) | 4.91047736 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.88622077 |
| 42 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.74544486 |
| 43 | T cell receptor signaling pathway (GO:0050852) | 4.65066591 |
| 44 | leukocyte aggregation (GO:0070486) | 4.61426702 |
| 45 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.57834410 |
| 46 | regulation of B cell mediated immunity (GO:0002712) | 4.57466146 |
| 47 | positive regulation of humoral immune response (GO:0002922) | 4.50604439 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 4.37148971 |
| 49 | T cell proliferation (GO:0042098) | 4.25044332 |
| 50 | positive regulation of tolerance induction (GO:0002645) | 4.22718787 |
| 51 | interferon-gamma production (GO:0032609) | 4.22197709 |
| 52 | negative regulation of cell killing (GO:0031342) | 4.20493401 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.20493401 |
| 54 | positive regulation of DNA recombination (GO:0045911) | 4.18461558 |
| 55 | regulation of isotype switching (GO:0045191) | 4.17551764 |
| 56 | positive regulation of immunoglobulin production (GO:0002639) | 4.14415982 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.13790297 |
| 58 | lymphocyte migration (GO:0072676) | 3.96768917 |
| 59 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.93180206 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92880635 |
| 61 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.91514626 |
| 62 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.89849684 |
| 63 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.88203837 |
| 64 | cellular response to interleukin-4 (GO:0071353) | 3.86235666 |
| 65 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.85825528 |
| 66 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.84269557 |
| 67 | positive regulation of T cell chemotaxis (GO:0010820) | 3.80922372 |
| 68 | regulation of T cell chemotaxis (GO:0010819) | 3.80922372 |
| 69 | T cell homeostasis (GO:0043029) | 3.74324585 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.71617863 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.67645376 |
| 72 | regulation of immunoglobulin production (GO:0002637) | 3.66557095 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65703848 |
| 74 | T cell mediated immunity (GO:0002456) | 3.64465212 |
| 75 | mast cell activation (GO:0045576) | 3.56472054 |
| 76 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.55434986 |
| 77 | negative regulation of interleukin-2 production (GO:0032703) | 3.46462137 |
| 78 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42348205 |
| 79 | T cell activation (GO:0042110) | 3.39349136 |
| 80 | response to interleukin-4 (GO:0070670) | 3.38117438 |
| 81 | positive regulation of T cell cytokine production (GO:0002726) | 3.36898101 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34610288 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 3.33877006 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 3.29991311 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26875578 |
| 86 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.26072258 |
| 87 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.25603149 |
| 88 | regulation of interleukin-2 production (GO:0032663) | 3.20285001 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 3.20104842 |
| 90 | positive regulation of response to biotic stimulus (GO:0002833) | 3.16506589 |
| 91 | T cell differentiation (GO:0030217) | 3.15127534 |
| 92 | natural killer cell activation (GO:0030101) | 3.14318482 |
| 93 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12592856 |
| 94 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.09713820 |
| 95 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.09458003 |
| 96 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06600486 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.02081195 |
| 98 | regulation of leukocyte mediated immunity (GO:0002703) | 3.01238316 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98497417 |
| 100 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.95793158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.40168365 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.11191836 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.60661023 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.29118797 |
| 5 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.22033302 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77478308 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69996008 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.63739264 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.47219815 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.22993917 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.10255296 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.96445327 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91295420 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.79985499 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77535161 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.77024451 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.61645116 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56158606 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44800572 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44084471 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38501454 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26082160 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.25155261 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.16151229 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13529704 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.12599912 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11379215 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08056263 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94487382 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85474306 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82756928 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74707758 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74686921 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70928550 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66343575 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65396694 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63264440 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61746947 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57875424 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57580308 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55245373 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54741704 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53980411 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.48722549 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47818613 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43711506 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39981316 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39232333 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38465967 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.36286097 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33424438 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30490900 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23025847 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21567479 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20585899 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18701770 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18552256 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18270167 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17876278 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.13461997 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11095674 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08854495 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07625796 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07449737 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04346094 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02560966 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01415506 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99294900 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98515517 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98088305 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95818859 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95216658 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95079420 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94773203 |
| 75 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.92422737 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92107481 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91437237 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90479781 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90281533 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88272990 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88170837 |
| 82 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.88127421 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86497121 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84680164 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84034686 |
| 86 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82906237 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82417720 |
| 88 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81933799 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81745646 |
| 90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81078763 |
| 91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.80807502 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80032016 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79501231 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77624389 |
| 95 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.76829725 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76769834 |
| 97 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.75656009 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.75393880 |
| 99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.74525495 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73270696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.24723872 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.45627813 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.93871360 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.65083081 |
| 5 | MP0009785_altered_susceptibility_to | 3.41550656 |
| 6 | MP0006082_CNS_inflammation | 3.41195614 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 3.35052419 |
| 8 | MP0000685_abnormal_immune_system | 3.22300343 |
| 9 | MP0002006_tumorigenesis | 2.97985675 |
| 10 | MP0001800_abnormal_humoral_immune | 2.92383632 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.90030413 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.83955171 |
| 13 | MP0002398_abnormal_bone_marrow | 2.82576047 |
| 14 | MP0001819_abnormal_immune_cell | 2.77948715 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.71694312 |
| 16 | MP0002723_abnormal_immune_serum | 2.69165244 |
| 17 | MP0005025_abnormal_response_to | 2.68829352 |
| 18 | MP0000703_abnormal_thymus_morphology | 2.63835803 |
| 19 | MP0002405_respiratory_system_inflammati | 2.56900645 |
| 20 | MP0003724_increased_susceptibility_to | 2.55760298 |
| 21 | MP0003436_decreased_susceptibility_to | 2.55519840 |
| 22 | MP0000716_abnormal_immune_system | 2.43685527 |
| 23 | MP0005387_immune_system_phenotype | 2.39315456 |
| 24 | MP0001790_abnormal_immune_system | 2.39315456 |
| 25 | MP0002933_joint_inflammation | 2.30681495 |
| 26 | MP0002722_abnormal_immune_system | 2.29589720 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.19927264 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.13462376 |
| 29 | MP0001873_stomach_inflammation | 2.01704902 |
| 30 | MP0003866_abnormal_defecation | 2.00066270 |
| 31 | MP0002429_abnormal_blood_cell | 1.98671530 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.97155104 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.96428801 |
| 34 | MP0004947_skin_inflammation | 1.85459280 |
| 35 | MP0000858_altered_metastatic_potential | 1.75228328 |
| 36 | MP0003448_altered_tumor_morphology | 1.70221781 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.68426279 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.68012488 |
| 39 | MP0002132_abnormal_respiratory_system | 1.62639962 |
| 40 | MP0002419_abnormal_innate_immunity | 1.60700152 |
| 41 | MP0001853_heart_inflammation | 1.46014134 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.44533267 |
| 43 | MP0004510_myositis | 1.42139797 |
| 44 | MP0000604_amyloidosis | 1.17500770 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.13406862 |
| 46 | MP0004957_abnormal_blastocyst_morpholog | 1.13124070 |
| 47 | MP0002019_abnormal_tumor_incidence | 1.12666961 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.09732913 |
| 49 | MP0003303_peritoneal_inflammation | 1.09503042 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.09200292 |
| 51 | MP0008469_abnormal_protein_level | 1.08056909 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.06298779 |
| 53 | MP0001958_emphysema | 1.00619762 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 0.99327381 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 0.98704744 |
| 56 | MP0008057_abnormal_DNA_replication | 0.96290191 |
| 57 | MP0005310_abnormal_salivary_gland | 0.92686288 |
| 58 | MP0003077_abnormal_cell_cycle | 0.91111528 |
| 59 | MP0003045_fibrosis | 0.89996913 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 0.88940846 |
| 61 | MP0009763_increased_sensitivity_to | 0.86651950 |
| 62 | MP0005023_abnormal_wound_healing | 0.86576714 |
| 63 | MP0005166_decreased_susceptibility_to | 0.73448618 |
| 64 | MP0004381_abnormal_hair_follicle | 0.73336286 |
| 65 | MP0000490_abnormal_crypts_of | 0.70654596 |
| 66 | MP0001851_eye_inflammation | 0.67474930 |
| 67 | MP0005360_urolithiasis | 0.66830048 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.65875039 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.65875039 |
| 70 | MP0002822_catalepsy | 0.65472368 |
| 71 | MP0000609_abnormal_liver_physiology | 0.64806463 |
| 72 | MP0000920_abnormal_myelination | 0.63351201 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.61468201 |
| 74 | MP0010094_abnormal_chromosome_stability | 0.60012246 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.58669958 |
| 76 | MP0001243_abnormal_dermal_layer | 0.58283241 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.53346419 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.52067920 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.52043801 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51535552 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.51497051 |
| 82 | MP0010307_abnormal_tumor_latency | 0.51465135 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.48570515 |
| 84 | MP0008873_increased_physiological_sensi | 0.47563137 |
| 85 | MP0002083_premature_death | 0.46558332 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.46223170 |
| 87 | MP0000477_abnormal_intestine_morphology | 0.45872071 |
| 88 | MP0005451_abnormal_body_composition | 0.44050259 |
| 89 | MP0003795_abnormal_bone_structure | 0.43103189 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.42183819 |
| 91 | MP0000598_abnormal_liver_morphology | 0.41315463 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.40409189 |
| 93 | MP0001730_embryonic_growth_arrest | 0.38691279 |
| 94 | MP0003075_altered_response_to | 0.37529466 |
| 95 | MP0001663_abnormal_digestive_system | 0.37524600 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.37416708 |
| 97 | MP0000249_abnormal_blood_vessel | 0.34472471 |
| 98 | MP0003111_abnormal_nucleus_morphology | 0.33965168 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.33518527 |
| 100 | MP0001191_abnormal_skin_condition | 0.33399603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.83836379 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.56815697 |
| 3 | Nasal polyposis (HP:0100582) | 7.23456648 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.76063346 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 6.36057123 |
| 6 | Chronic otitis media (HP:0000389) | 6.07813374 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 6.00556287 |
| 8 | Combined immunodeficiency (HP:0005387) | 5.79621328 |
| 9 | Myositis (HP:0100614) | 5.48298849 |
| 10 | Eczematoid dermatitis (HP:0000976) | 5.06198484 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 5.03438295 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.95682631 |
| 13 | Abnormality of T cells (HP:0002843) | 4.93435998 |
| 14 | Recurrent viral infections (HP:0004429) | 4.03908191 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.01049924 |
| 16 | Stomatitis (HP:0010280) | 4.00086007 |
| 17 | Joint swelling (HP:0001386) | 3.98161484 |
| 18 | Pustule (HP:0200039) | 3.98154963 |
| 19 | IgG deficiency (HP:0004315) | 3.73017613 |
| 20 | Lymphopenia (HP:0001888) | 3.62646498 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.58962359 |
| 22 | Optic neuritis (HP:0100653) | 3.58962359 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 3.55450656 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.54357295 |
| 25 | Abnormality of eosinophils (HP:0001879) | 3.48625654 |
| 26 | Eosinophilia (HP:0001880) | 3.47299108 |
| 27 | Hypoplasia of the thymus (HP:0000778) | 3.32906029 |
| 28 | Recurrent abscess formation (HP:0002722) | 3.30375376 |
| 29 | Leukocytosis (HP:0001974) | 3.29627173 |
| 30 | Abnormality of B cell number (HP:0010975) | 3.27977427 |
| 31 | B lymphocytopenia (HP:0010976) | 3.27977427 |
| 32 | Orchitis (HP:0100796) | 3.15345094 |
| 33 | Increased IgM level (HP:0003496) | 3.06697412 |
| 34 | Chronic sinusitis (HP:0011109) | 3.01524480 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99476397 |
| 36 | Thyroiditis (HP:0100646) | 2.99295780 |
| 37 | Encephalitis (HP:0002383) | 2.97569574 |
| 38 | Granulocytopenia (HP:0001913) | 2.94401803 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.92326601 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 2.82951158 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.77270544 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.77270544 |
| 43 | Meningitis (HP:0001287) | 2.76821695 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.74927355 |
| 45 | Hypoproteinemia (HP:0003075) | 2.69562363 |
| 46 | Bronchitis (HP:0012387) | 2.66525956 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.62193909 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.58945733 |
| 49 | Hemoptysis (HP:0002105) | 2.57463317 |
| 50 | Lymphoma (HP:0002665) | 2.53671343 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.51842869 |
| 52 | Chronic diarrhea (HP:0002028) | 2.47061693 |
| 53 | IgM deficiency (HP:0002850) | 2.45118408 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.39385442 |
| 55 | Pulmonary embolism (HP:0002204) | 2.38326977 |
| 56 | Arterial thrombosis (HP:0004420) | 2.37454197 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.35437767 |
| 58 | Recurrent skin infections (HP:0001581) | 2.34529229 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.32725068 |
| 60 | Thrombocytosis (HP:0001894) | 2.32525666 |
| 61 | Vasculitis (HP:0002633) | 2.27264352 |
| 62 | Trigonocephaly (HP:0000243) | 2.27206737 |
| 63 | Recurrent otitis media (HP:0000403) | 2.24524734 |
| 64 | Basal cell carcinoma (HP:0002671) | 2.18808832 |
| 65 | Frequent falls (HP:0002359) | 2.13734146 |
| 66 | Abnormality of oral frenula (HP:0000190) | 2.09119372 |
| 67 | Gangrene (HP:0100758) | 2.07560106 |
| 68 | Amyotrophic lateral sclerosis (HP:0007354) | 2.04329791 |
| 69 | Increased IgE level (HP:0003212) | 2.03581245 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.03032372 |
| 71 | Hemiplegia (HP:0002301) | 2.00923751 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00546432 |
| 73 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.99427659 |
| 74 | Obstructive lung disease (HP:0006536) | 1.98726235 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98726235 |
| 76 | Bronchiectasis (HP:0002110) | 1.96101546 |
| 77 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.95592649 |
| 78 | Recurrent sinusitis (HP:0011108) | 1.93908355 |
| 79 | Microcytic anemia (HP:0001935) | 1.92599944 |
| 80 | Abnormality of the pleura (HP:0002103) | 1.83105862 |
| 81 | Epistaxis (HP:0000421) | 1.75762188 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 1.75428201 |
| 83 | Emphysema (HP:0002097) | 1.73456748 |
| 84 | Bicuspid aortic valve (HP:0001647) | 1.69413889 |
| 85 | Arthralgia (HP:0002829) | 1.69411349 |
| 86 | Abnormal platelet volume (HP:0011876) | 1.68834980 |
| 87 | Skin ulcer (HP:0200042) | 1.68191879 |
| 88 | Aplastic anemia (HP:0001915) | 1.67534763 |
| 89 | Anorexia (HP:0002039) | 1.67519200 |
| 90 | Inflammation of the large intestine (HP:0002037) | 1.67111770 |
| 91 | Amaurosis fugax (HP:0100576) | 1.66681076 |
| 92 | Petechiae (HP:0000967) | 1.65953873 |
| 93 | Prominent metopic ridge (HP:0005487) | 1.65710480 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 1.62380711 |
| 95 | Periodontitis (HP:0000704) | 1.62094719 |
| 96 | Chest pain (HP:0100749) | 1.61966914 |
| 97 | Gingival bleeding (HP:0000225) | 1.61782321 |
| 98 | Diplopia (HP:0000651) | 1.61767675 |
| 99 | Abnormality of binocular vision (HP:0011514) | 1.61767675 |
| 100 | Abnormality of the endocardium (HP:0004306) | 1.61381093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.61941993 |
| 2 | TXK | 5.05938427 |
| 3 | ITK | 4.26443261 |
| 4 | ZAP70 | 3.86302112 |
| 5 | FGFR4 | 3.58784699 |
| 6 | JAK3 | 2.91693061 |
| 7 | KDR | 2.73634466 |
| 8 | TYK2 | 2.64429685 |
| 9 | NME2 | 2.62712651 |
| 10 | LCK | 2.31286515 |
| 11 | CSK | 2.21887772 |
| 12 | IKBKE | 2.19219629 |
| 13 | JAK1 | 2.17467046 |
| 14 | MAP3K14 | 1.98261251 |
| 15 | STK10 | 1.95758208 |
| 16 | TBK1 | 1.86313138 |
| 17 | FGFR3 | 1.79041853 |
| 18 | PRKCH | 1.61660677 |
| 19 | MST4 | 1.58253124 |
| 20 | TRIB3 | 1.50257234 |
| 21 | GRK6 | 1.49892532 |
| 22 | BLK | 1.49593445 |
| 23 | SYK | 1.49587013 |
| 24 | EPHA3 | 1.48625946 |
| 25 | FGFR1 | 1.38413073 |
| 26 | BUB1 | 1.36679394 |
| 27 | EEF2K | 1.33940103 |
| 28 | TEC | 1.32982274 |
| 29 | PKN2 | 1.30898351 |
| 30 | MAP2K6 | 1.24954684 |
| 31 | CLK1 | 1.24719663 |
| 32 | NLK | 1.22395662 |
| 33 | HCK | 1.17719546 |
| 34 | MAP3K13 | 1.17099719 |
| 35 | TESK2 | 1.14219917 |
| 36 | LRRK2 | 1.06995309 |
| 37 | EPHB1 | 1.02225507 |
| 38 | CDC7 | 1.00141229 |
| 39 | FES | 0.97085130 |
| 40 | KIT | 0.95753918 |
| 41 | LYN | 0.95007918 |
| 42 | PRKCQ | 0.94396615 |
| 43 | TSSK6 | 0.90257328 |
| 44 | TAOK1 | 0.88096179 |
| 45 | BTK | 0.84761974 |
| 46 | MAP3K10 | 0.83426025 |
| 47 | JAK2 | 0.81469701 |
| 48 | SIK2 | 0.81043394 |
| 49 | MAP3K11 | 0.80586917 |
| 50 | RAF1 | 0.80279675 |
| 51 | MAP3K7 | 0.80179606 |
| 52 | SCYL2 | 0.79146461 |
| 53 | ALK | 0.76626206 |
| 54 | INSR | 0.71601594 |
| 55 | IKBKB | 0.69889208 |
| 56 | MELK | 0.66251885 |
| 57 | CSF1R | 0.62794378 |
| 58 | TYRO3 | 0.58941534 |
| 59 | PASK | 0.58233842 |
| 60 | FYN | 0.56893348 |
| 61 | MAP3K8 | 0.53524782 |
| 62 | PDK1 | 0.52270213 |
| 63 | PIM2 | 0.50200474 |
| 64 | PDGFRB | 0.47976123 |
| 65 | EGFR | 0.43598923 |
| 66 | FGFR2 | 0.43221245 |
| 67 | MAPK11 | 0.42001052 |
| 68 | CDK4 | 0.41025152 |
| 69 | ACVR1B | 0.40453888 |
| 70 | RPS6KB2 | 0.40224485 |
| 71 | TLK1 | 0.39962302 |
| 72 | MAP2K3 | 0.36471125 |
| 73 | CHUK | 0.36371744 |
| 74 | PIM1 | 0.36168613 |
| 75 | IGF1R | 0.33497858 |
| 76 | CDK8 | 0.31422405 |
| 77 | NTRK2 | 0.27294800 |
| 78 | SRC | 0.27210959 |
| 79 | RPS6KA4 | 0.25471097 |
| 80 | NEK2 | 0.25467430 |
| 81 | TAOK2 | 0.23481980 |
| 82 | PRPF4B | 0.22625293 |
| 83 | ILK | 0.22325071 |
| 84 | MARK3 | 0.21997186 |
| 85 | TNK2 | 0.21879112 |
| 86 | DAPK1 | 0.21265867 |
| 87 | SIK1 | 0.20180488 |
| 88 | MAP3K12 | 0.18845565 |
| 89 | PRKCD | 0.18292178 |
| 90 | GSK3A | 0.17909158 |
| 91 | AURKB | 0.17087845 |
| 92 | HIPK2 | 0.16809117 |
| 93 | TTN | 0.16704027 |
| 94 | ABL1 | 0.16005231 |
| 95 | KSR2 | 0.15593280 |
| 96 | CDK19 | 0.15237730 |
| 97 | MAPK9 | 0.14416945 |
| 98 | MAPK3 | 0.13652067 |
| 99 | ERN1 | 0.12426580 |
| 100 | TGFBR1 | 0.12406130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 6.42007321 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.60391904 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.13210700 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.87756281 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.69526676 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.51552774 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.99560844 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.86057405 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.50634405 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.37930402 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09998165 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04206671 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99905224 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 1.96219838 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.63430877 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48393889 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47289537 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46970617 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.44980584 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41035316 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39944241 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30627293 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29960004 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25919640 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.23464173 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17458543 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16271819 |
| 28 | HTLV-I infection_Homo sapiens_hsa05166 | 1.12717846 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11060371 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10350941 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06523207 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97591031 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 0.97330633 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 0.96945441 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 0.94684538 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94672746 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93208316 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92016568 |
| 39 | Asthma_Homo sapiens_hsa05310 | 0.89821816 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88227452 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 0.81475299 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80345183 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 0.79476959 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76199320 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73894404 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70524752 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70453185 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68352189 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.67959848 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67802694 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.67158878 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65959804 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65417874 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.64742390 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61698317 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58105898 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54260971 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52827551 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51683637 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51308806 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45744745 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.44336026 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.42974107 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.42053088 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40954559 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39294533 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34958511 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32573346 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.31803766 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31583314 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.31329219 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.22982593 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22794537 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.20571268 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20095241 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.18684878 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.18299400 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18090079 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17490420 |
| 80 | RNA transport_Homo sapiens_hsa03013 | 0.16592008 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16297292 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16056542 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15488889 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.13931258 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13706520 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13431733 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13262382 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.12902019 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.12173960 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.11010274 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10046422 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.08945083 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.08638475 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.07461678 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.07006739 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.05834075 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.01586430 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.00829070 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.00814431 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | -0.0013796 |

